CINCOR PHARMA INC (CINC) Stock News

CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat

WALTHAM, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor” or the “Company”) announced today completion of an End-of-Phase 2 meeting...

Where CinCor Pharma Stands With Analysts

AstraZeneca Stock Nabs Breakout After $1.8 Billion CinCor Buyout

CinCor will bolster AstraZeneca's growing cardio-renal business.

Mentions: AZN

12 Health Care Stocks Moving In Monday's Intraday Session

Mentions: ARWR CERS CUTR RVNC ...

CINCOR PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC

Why These Two Biotech Stocks Blasted Higher This Week

There's nothing like a big-premium buyout to send a company's share price to the moon.

Mentions: AZN ALBO

Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review

Sharp Tesla price cuts and some notable earnings were in focus.

Mentions: TSLA JPM UNH TSM ...

CINCOR PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC

SHAREHOLDER ALERT: Weiss Law Investigates CinCor Pharma, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CinCor Pharma, Inc....

Mentions: AZN

Hot Stocks: Crypto stocks rally; CINC, ALBO soar on M&A news; LULU slumps on guidance

Crypto stocks rallied, helped by a rise in Bitcoin. CINC and ALBO jumped on separate deals to be acquired. LULU dropped on guidance.

Mentions: COIN MARA HUT RIOT ...

Shareholder Alert: Ademi LLP investigates whether CinCor Pharma, Inc. has obtained a Fair Price in its transaction with AstraZeneca

/PRNewswire/ -- Ademi LLP is investigating CinCor (Nasdaq: CINC) for possible breaches of fiduciary duty and other violations of law in its transaction with...

AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal

AstraZeneca stock wavered as it agreed to buy CinCor Pharma, maker of blood pressure drug baxdrostat for $1.8 billion. CINC stock soared.

Mentions: AZN

Why Is CinCor (CINC) Stock Up 138% Today?

CinCor (CINC) stock is rocketing higher on Monday following news that AstraZeneca (AZN) is acquiring the company for up to $1.8 billion.

Mentions: AZN BBBY BABA TSLA

CINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CinCor Pharma, Inc. Is Fair to Shareholders